Request Deal Involvement

General Atlantic led a $250m Series A financing round in Centessa Pharmaceuticals.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

VEITHing Spirit

pr advisors

VEITHing Spirit

Optimum Strategic Communications

pr advisors

Optimum Strategic Communications

1AB

pr advisors

1AB

Goodwin Procter

legal advisors

Goodwin Procter

or

Principals

JANUS HENDERSON INVESTORS

bidder

JANUS HENDERSON INVESTORS

BVF PARTNERS

bidder

BVF PARTNERS

LOGOS CAPITAL

bidder

LOGOS CAPITAL

T. ROWE PRICE GROUP INC

bidder

T. ROWE PRICE GROUP INC

SAMSARA BIOCAPITAL

bidder

SAMSARA BIOCAPITAL

CORMORANT ASSET MANAGEMENT

bidder

CORMORANT ASSET MANAGEMENT

VENROCK

bidder

VENROCK

ECOR1 CAPITAL

bidder

ECOR1 CAPITAL

WELLINGTON MANAGEMENT

bidder

WELLINGTON MANAGEMENT

GENERAL ATLANTIC LLC

bidder

GENERAL ATLANTIC LLC

BOXER CAPITAL

bidder

BOXER CAPITAL

CENTESSA PHARMACEUTICALS

target

CENTESSA PHARMACEUTICALS

VIDA VENTURES

bidder

VIDA VENTURES

LIFESCI VENTURE PARTNERS

bidder

LIFESCI VENTURE PARTNERS

FRANKLIN TEMPLETON INVESTMENTS CORPORATION

bidder

FRANKLIN TEMPLETON INVESTMENTS CORPORATION

MEDICXI VENTURES

bidder

MEDICXI VENTURES

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite